Vor Biopharma Inc.

Nasdaq:VOR

Biological Products, (No Diagnostic Substances)·BOSTON, MA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q/A	Q1 2024	3/31/24	8/8/24	→
↓

Earnings Releases (8-K)

1 shown

Filed	Period
1/12/26	Q4 FY2026	→

News (8-K)

43 shown

Filed	Type	Description
1/2/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/18/25	Exec Change	Entry into a Material Definitive Agreement	→
12/9/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/12/25	Other	Other Events	→
11/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/28/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

31 shown

Filed	Form	Description
2/5/26	424B3	424B3	→
1/29/26	S-3	S-3	→
12/1/25	424B3	424B3	→
11/12/25	424B5	424B5	→
11/10/25	424B5	424B5	→
11/10/25	S-3/A	S-3/A	→
↓

Filing History(402 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 17, 2026

0002088344-26-000003

—

9.0 KB

SCHEDULE 13G/A

Feb 17, 2026

0001738048-26-000034

—

18.4 KB

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001109

—

11.2 KB

SCHEDULE 13G/A

Feb 17, 2026

0001104659-26-016357

—

12.1 KB

SCHEDULE 13G/A

Feb 13, 2026

0001910025-26-000004

—

12.8 KB

424B3

Feb 5, 2026

0001193125-26-039378424B3

—

169.2 KB

SCHEDULE 13G/A

Feb 5, 2026

0000315066-26-000557

—

11.2 KB

EFFECT

Feb 4, 2026

9999999995-26-000446

—

1.7 KB

S-3

Jan 29, 2026

0001193125-26-029364S-3

—

372.3 KB

8-K

Jan 12, 2026

0001193125-26-0099618-K

Jan 12, 2026

7.6 MB

8-K

Jan 2, 2026

0001193125-26-0009058-K

Dec 31, 2025

239.6 KB

SCHEDULE 13D

Dec 23, 2025

0001193125-25-330843

—

140.4 KB

Dec 19, 2025

0001231919-25-000644

Dec 18, 2025

13.3 KB

Dec 19, 2025

0001897813-25-000010

Dec 18, 2025

11.5 KB

Dec 19, 2025

0001867539-25-000006

Dec 18, 2025

5.9 KB

Dec 19, 2025

0001897813-25-000008

Dec 18, 2025

3.0 KB

Dec 19, 2025

0001867539-25-000004

Dec 18, 2025

9.2 KB

SCHEDULE 13G

Dec 19, 2025

0001231919-25-000641

—

27.9 KB

SCHEDULE 13D/A

Dec 18, 2025

0001346824-25-000081

—

20.0 KB

8-K

Dec 18, 2025

0001193125-25-3247688-K

Dec 15, 2025

909.3 KB

SCHEDULE 13G

Dec 17, 2025

0001172661-25-005271

—

13.6 KB

Dec 9, 2025

0001511034-25-000006

Dec 5, 2025

13.3 KB

Dec 9, 2025

0002079210-25-000003

Dec 5, 2025

14.3 KB

Dec 9, 2025

0001654979-25-000006

Dec 5, 2025

14.2 KB

8-K

Dec 9, 2025

0001193125-25-3119578-K

Dec 5, 2025

155.9 KB

25 filings shown

Filed	Form	Description
8/8/25	DEF 14A	DEF 14A	→
7/29/25	PRE 14A	PRE 14A	→
4/30/25	DEFR14A	DEFR14A	→
4/8/25	DEFA14A	DEFA14A	→
4/8/25	DEF 14A	DEF 14A	→
3/28/25	PRE 14A	PRE 14A	→
↓

Vor Biopharma Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(402 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/19/25	4	4	→
12/19/25	4	4	→
12/19/25	4	4	→
12/19/25	3	3	→
12/19/25	3	3	→
12/9/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/5/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓